Oral Tofacitinib for Recalcitrant Lichen Planus Pigmentosus: A Hospital-Based Retrospective Study
June 2026
in “
Journal of General-Procedural Dermatology & Venereology Indonesia
”
Studysummary This study concluded that oral tofacitinib significantly improved symptoms in patients with lichen planus pigmentosus who did not respond to conventional treatments, showing it as a viable alternative.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on scholarhub.ui.ac.id →